Chondroprotective effect of high-dose zoledronic acid: An experimental study in a rabbit model of osteoarthritis

Journal of Orthopaedic Research

Volumn 32, Issue 12, 2014, Pages 1646-1651

  Lampropoulou Adamidou, Kalliopi ^a   Dontas, Ismene ^a   Stathopoulos, Ioannis P ^a   Khaldi, Lubna ^a,b   Lelovas, Pavlos ^a   Vlamis, John ^a   Triantafillopoulos, Ioannis K ^a   Papaioannou, Nikolaos A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b AMALIA FLEMING GENERAL HOSPITAL   (Greece)

Author keywords

Animal model; Cartilage; Osteoarthritis; Subchondral bone; Zoledronic acid

Indexed keywords

PLACEBO; SODIUM CHLORIDE; ZOLEDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; ARTICULAR CARTILAGE; BONE NECROSIS; CARTILAGE CELL; CHONDROPROTECTION; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISORIENTATION; DRUG MEGADOSE; EUTHANASIA; EXPERIMENTAL STUDY; HISTOPATHOLOGY; MALE; MICROSCOPY; MOLECULAR CLONING; NONHUMAN; OSTEOARTHRITIS; OSTEOLYSIS; OSTEOPHYTE; RABBIT MODEL; REGENERATION; ULCER; ANIMAL; DISEASE MODEL; DRUG EFFECTS; RABBIT;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; CHONDROCYTES; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; IMIDAZOLES; MALE; OSTEOARTHRITIS; RABBITS;

EID: 84911806047     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22712     Document Type: Article

References (31)

1. Gore M, Tai KS, Sadosky A, et al. 2011. Clinical comorbid-ities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis. J Med Econ 14:497-507.
2. Baker-LePain JC, Lane NE. 2012. Role of bone architecture and anatomy in osteoarthritis. Bone 51: 197-203.
3. Madry H, van Dijk CN, Mueller-Gerbl M. 2010. The basic science of the subchondral bone. Knee Surg Sports Trauma-tol Arthrosc 18:419-433.
4. Papapetrou PD. 2009. Bisphosphonate-associated adverse events. Hormones (Athens) 8:96-110.
5. Bingham CO, Buckland-Wright JC, Garnero P, et al. 2006. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radio-graphic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 54:3494-3507.
6. Hadji P, Gamerdinger D, Spieler W, et al. 2012. Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass. Osteoporos Int 23:625-633.
7. Mohan G, Perilli E, Parkinson IH, et al. 2013. Pre-emptive, early, and delayed alendronate treatment in a rat model of knee osteoarthritis: effect on subchondral trabecular bone microarchitecture and cartilage degradation of the tibia, bone/cartilage turnover, and joint discomfort. Osteoarthritis Cartilage 21:1595-1604.
8. Muehleman C, Green J, Williams JM, et al. 2002. The effect of bone remodeling inhibition by zoledronic acid in an animal model of cartilage matrix damage. Osteoarthritis Cartilage 10:226-233.
9. Shirai T, Kobayashi M, Nishitani K, et al. 2011. Chondro-protective effect of alendronate in a rabbit model of osteoar-thritis. J Orthop Res 29:1572-1577.
10. Spector TD, Conaghan PG, Buckland-Wright JC, et al. 2005. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res Ther 7: R625-633.
11. Strassle BW, Mark L, Leventhal L, et al. 2010. Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease. Osteoarthritis Cartilage 18: 1319-1328.
12. Yu DG, Yu B, Mao YQ, et al. 2012. Efficacy of zoledronic acid in treatment of teoarthritis is dependent on the disease progression stage in rat medial meniscal tear model. Acta Pharmacol Sin 33:924-934.
13. Zhang L, Hu H, Tian F, et al. 2011. Enhancement of subchondral bone quality by alendronate administration for the reduction of cartilage degeneration in the early phase of experimental osteoarthritis. Clin Exp Med 11:235-243.
14. Corrado A, Santoro N, Cantatore FP. 2007. Extra-skeletal effects of bisphosphonates. Joint Bone Spine 74:32-38.
15. Lampropoulou-Adamidou K, Lelovas P, Karadimas EV, et al. 2014. Useful animal models for the research of osteoarthritis. Eur J Orthop Surg Traumatol 24:263-271.
16. Mankin HJ, Dorfman H, Lippiello L, Zarins A. 1971. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53:523-537.
17. Pearson RG, Kurien T, Shu KS, Scammell BE. 2011. Histopathology grading systems for characterisation of human knee osteoarthritis-reproducibility, variability, reliability, correlation, and validity. Osteoarthritis Cartilage 19: 324-331.
18. Bettica P, Cline G, Hart DJ, et al. 2002. Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study. Arthritis Rheum 46:3178-3184.
19. Beuf O, Ghosh S, Newitt DC, et al. 2002. Magnetic resonance imaging of normal and osteoarthritic trabecular bone structure in the human knee. Arthritis Rheum 46:385-393.
20. Calvo E, Castaneda S, Largo R, et al. 2007. Osteoporosis increases the severity of cartilage damage in an experimental model of osteoarthritis in rabbits. Osteoarthritis Cartilage 15:69-77.
21. Dedrick DK, Goldstein SA, Brandt KD, et al. 1993. A longitudinal study of subchondral plate and trabecular bone in cruciate-deficient dogs with osteoarthritis followed up for 54 months. Arthritis Rheum 36:1460-1467.
22. Dore D, Quinn S, Ding C, et al. 2009. Correlates of subchondral BMD: a cross-sectional study. J Bone Miner Res 24:2007-2015.
23. Radin EL, Rose RM. 1986. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop Relat Res 34-40.
24. Kwan Tat S, Lajeunesse D, Pelletier JP, Martel-Pelletier J. 2010. Targeting subchondral bone for treating osteoarthritis: what is the evidence? Best Pract Res Clin Rheumatol 24: 51-70.
25. Papaioannou NA, Triantafillopoulos IK, Khaldi L, et al. 2007. Effect of calcitonin in early and late stages of experimentally induced osteoarthritis. A histomorphometric study. Osteoarthritis Cartilage 15:386-395.
26. Carbone LD, Nevitt MC, Wildy K, et al. 2004. The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 50:3516-3525.
27. Papaioannou N, Krallis N, Triantafillopoulos I, et al. 2004. Optimal timing of research after anterior cruciate ligament resection in rabbits. Contemp Top Lab Anim Sci 43:22-27 quiz 58.
28. Yoshioka M, Coutts RD, Amiel D, Hacker SA. 1996. Characterization of a model of osteoarthritis in the rabbit knee. Osteoarthritis Cartilage 4:87-98.
29. Poole CA. 1997. Articular cartilage chondrons: form, function and failure. J Anat 191:1-13.
30. Quintavalla J, Kumar C, Daouti S, et al. 2005. Chondrocyte cluster formation in agarose cultures as a functional assay to identify genes expressed in osteoarthritis. J Cell Physiol 204:560-566.
31. Bendele AM. 2001. Animal models of osteoarthritis. J Musculoskelet Neuronal Interact 1:363-376.